Latest headlines

Loading...

Propecia Generic For Male Pattern Baldness

The drug propecia generic was originally intended for treating prostate enlargement or benign prostatic hyperplasia. When its branded name Proscar was released in the market, it was noticed that men who were suffering from androgenic alopecia were also being treated by the drug.  It was then that the manufacturer took notice and created some clinical studies and found out that Proscar, which came at 5mg, which at lowered dosage, particularly 1mg, could help fight androgenic alopecia.  Several years later, the brand Propecia, an offshoot of the drug Proscar was approved by the Food and Drug Administration as a treatment for androgenic alopecia.

Who is propecia generic intended for?

Propecia generic is meant for men suffering from male pattern baldness and want to stop the progression of their hair loss.  Signs of male pattern baldness would be the thinning of hair on the front, the receding of hairline on the temples, and the formation of a bald spot on the crown.  In due time, this type of baldness will let you end up bald from top to front with a rim of hair at the sides and back.  propecia generic is effective against this type of hair loss because it is able to treat it at the root of the cause – the formation of the hormone dihydrotestosterone (DHT).  Basically, this hair loss treatment prevents your hair loss from getting any worse.  If your hair loss is due to androgenic alopecia, then this is the medication for you.  Consult your doctor to know what type of hair loss you are having. Read more…

Nova Scotia doctors approve new contract with government

A new agreement between Nova Scotia's physicians and the provincial government has been approved by Doctors Nova Scotia's membership, the organization announced today.

The five-year agreement, retroactive to April 1, was approved by a 71% vote.

In a news release, Doctors Nova Scotia president Dr Don Pugsley (left) said:

"This agreement is different. Rather than simply offering an across-the board fee increase, this agreement supports system change... The physicians of Nova Scotia asked us to find ways to support them in providing care that is innovative and better focused on patient needs. [...]

"This agreement will help ensure patients have access to the care they need, when they need it, whether their condition is simple or complex. This agreement also facilitates our ability to work with other health-care professionals to deliver collaborative care.

“It won’t solve all of our health-care issues, but it’s a step in the right direction. It will strengthen our ability to deliver the highest quality patient care – a high priority for our members.”
Doctors Nova Scotia announced that the new agreement, which will be in effect until March 31, 2013, includes:
  • a focus on encouraging doctors to provide a broad spectrum of care to their patients;
  • new funding to help retain rural specialists;
  • funding to support collaborative care with other health-care providers;
  • more funding to support general practitioners who provide comprehensive care, chronic disease management and in-hospital care; and
  • funds to address unforeseen issues that may arise throughout the life of the agreement.
This new contract follows the provincial government's new strategy that was released in January as a report called the Provincial Health Services Operational Review, or PHSOR for short. (Strangely, it's pronounced 'fa-ZORE' by those in the know. Really.)

You can read more about that strategy in this article from the National Review of Medicine's February 2008 issue. In our article, Dr Pugsley endorsed the review, saying, "Certainly we believe it's past time for change and modernization of the healthcare system in Nova Scotia."

Today's approval of the new agreement with the government, he says, is another step in that direction.


Photo: Doctors Nova Scotia

Check out our website: www.nationalreviewofmedicine.com

Newer Post Older Post Home